Russell Investments Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-59,697
| Closed | -$6.41M | – | 3570 |
|
|
2023
Q1 | $6.41M | Buy |
59,697
+16,020
| +37% | +$1.72M | 0.01% | 989 |
|
|
2022
Q4 | $4.8M | Sell |
43,677
-40,499
| -48% | -$4.45M | 0.01% | 1113 |
|
|
2022
Q3 | $4.96M | Buy |
84,176
+45,466
| +117% | +$2.68M | 0.01% | 1055 |
|
|
2022
Q2 | $1.09M | Sell |
38,710
-20,506
| -35% | -$578K | ﹤0.01% | 1916 |
|
|
2022
Q1 | $2.23M | Buy |
+59,216
| New | +$2.23M | ﹤0.01% | 1585 |
|